| Medicare Noridian | Billing and Coding: MolDX: EndoPredict– Breast Cancer Gene Expression Test (57607) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma) (57621) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Inivata–, InVisionFirst–, Liquid Biopsy for Patients with Lung Cancer (57664) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Breast Cancer Index– (BCI) Gene Expression Test (57773) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer (58718) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia (59032) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma (59179) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma (59386) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy (59505) | 2026-01-12 |
| Medicare Noridian | Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers (59513) | 2026-01-12 |